Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 726 JPY 0.64%
Market Cap: 43B JPY

Fuji Pharma Co Ltd
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Fuji Pharma Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Pre-Tax Income
ÂĄ4.2B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
3%
Takeda Pharmaceutical Co Ltd
TSE:4502
Pre-Tax Income
ÂĄ97.9B
CAGR 3-Years
-26%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Pre-Tax Income
ÂĄ326.3B
CAGR 3-Years
61%
CAGR 5-Years
22%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Pre-Tax Income
ÂĄ472.6B
CAGR 3-Years
49%
CAGR 5-Years
20%
CAGR 10-Years
8%
Chugai Pharmaceutical Co Ltd
TSE:4519
Pre-Tax Income
ÂĄ553.4B
CAGR 3-Years
-12%
CAGR 5-Years
15%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Pre-Tax Income
ÂĄ136.8B
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
42.2B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 283.9 JPY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Pre-Tax Income?
Pre-Tax Income
4.2B JPY

Based on the financial report for Jun 30, 2025, Fuji Pharma Co Ltd's Pre-Tax Income amounts to 4.2B JPY.

What is Fuji Pharma Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
3%

Over the last year, the Pre-Tax Income growth was -51%. The average annual Pre-Tax Income growth rates for Fuji Pharma Co Ltd have been 6% over the past three years , 12% over the past five years , and 3% over the past ten years .

Back to Top